N/A
N=50
Evaluation of a Patient Portal Intervention to Address Diabetes Care Gaps
Diabetes Mellitus
Bottom Line
View on ClinicalTrials.gov: NCT04728620 ↗Enrolled (actual)
50
Serious AEs
6.0%
Results posted
Aug 2023
Primary outcome: Primary: Usability — 79.3 score on a scale — p=0.001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Diabetes Care Gaps Patient Portal Intervention (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Vanderbilt University Medical Center
- Primary completion
- May 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Usability |
79.3 | 0.001 sig |
| PRIMARY User Experience |
37; 10; 38; 9 | — |
| SECONDARY Change in Attitudes Toward Managing Diabetes in General |
8.1; 8.6 | 0.005 sig |
| SECONDARY Change in Diabetes Distress |
6.6; 5.8 | 0.19 |
| SECONDARY Change in Understanding of Diabetes Monitoring and Preventative Care |
38; 38; 24; 23; 13; 13 | 1 |
| SECONDARY Patient Initiated Orders |
14; 17; 6; 10 | — |
| SECONDARY Order Completion |
13; 15; 6; 5 | — |
Summary
The purpose of this study is to evaluate the usability of a novel patient portal intervention designed to: (a) notify patients when selected, clinically meaningful, evidence-based diabetes monitoring & preventative care (e.g., annual diabetes eye exam) become due and (b) allow patients to initiate orders for the care. In addition, the investigators will assess pre-post change on secondary psychosocial outcomes (e.g., self-efficacy).
Eligibility Criteria
Inclusion Criteria
- Established patient at participating primary care clinic
- Type 1 or 2 diabetes mellitus
- Able to speak and read in English
- Age 18 to 75 years old
- Mobile device (smartphone or tablet) with internet access
- Active MHAV account and willing and able to use the MHAV native app on a mobile device
- Due (based on evidence-based guidelines) for any of the following: hemoglobin A1C, urine microalbumin, diabetes eye exam, and/or pneumococcal vaccination.
Exclusion Criteria
- Known cognitive deficits or functional impairment preventing the use of a mobile device
- Pregnant or planning to become pregnant during the study period
- Severe difficulty seeing
- Severe difficulty hearing
- Medical condition that make it hard for people to understand what they are saying
Data sourced from ClinicalTrials.gov (NCT04728620). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.